Testing arpraziquantel for liver fluke in children
Part of Infections clinical trials.
This study tests if higher doses of arpraziquantel can safely treat children infected with the liver fluke Opisthorchis viverrini. It aims to find the best dose that clears the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is 6 or 7 years old (between 72 and 95 months).
- You and your child agree to give two stool samples before and three to four weeks after treatment.
- Your child will let a doctor examine them before taking the medicine.
- Stool tests at the start show a liver fluke infection (Opisthorchis viverrini).
- Your child has not taken any deworming medicine in the last 4 weeks.
- Your child does not have a serious illness like severe anemia (very low red blood cells).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called arpraziquantel to treat schistosomiasis (a disease from parasites in water) in young children aged 2 to 5. It aims to see if giving this treatment in communities where the disease is common is safe and helpful.
This trial tests two different schedules of the drug praziquantel to see which works better for treating liver scarring caused by a parasitic infection called schistosomiasis. It aims to improve liver health and prevent complications.
This study compares three medicines (albendazole, tribendimidine, and praziquantel) to see which works best for treating clonorchiasis (a liver fluke infection). If you have been diagnosed with this infection, this trial may help find the most effective treatment for you.
This study tests whether one or two doses of oxfendazole (a newer drug) works as well as the standard two-dose triclabendazole treatment for chronic fascioliasis (liver fluke infection). It may offer a simpler treatment option.
This trial studies which dose of oxfendazole works best and is safest for treating a specific intestinal worm infection in adults. It compares different oxfendazole doses to one standard dose of albendazole, and uses stool and blood testing over about 4–6 weeks.
This study tests the best dose of tafenoquine to treat people with symptoms from a malaria type called P. vivax and to help prevent it from coming back. You may be eligible if you recently had fever and meet specific blood and safety checks, especially G6PD level.
Hear when a new Opisthorchis Viverrini trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.